summary, our earnings growth and quarter, Thank third returned while were to you, In below in adjusted good Roz, morning. the we EPS expectations.
lower encountered and business, U.S. in XX%. respiratory a on incidences. by delivered behaviors, a we our plan, currency of our COVID growth slowdown ahead we Overall, sales constant led basis shifting recent pharmacy consumer up X.X% As contributions,
healthcare prior billion which U.K. added year. Boots business, versus $X.X solid our business, comp and sales a Our the in retail which delivered XX% scaling
points sale tax. incentive increased AmerisourceBergen. offset headwind EPS X.X% on These contribution a were point of from due constant ownership partly percentage and COVID-XX lower XX Adjusted X accruals, despite reduced favorability’s from percentage basis leaseback, and and by a a to currency
percentage items be X.X quality of in net a quarter. of EPS overall demonstrates All and out growth headwind to this the these good earnings point to
to we COVID around fiscal $X.XX guidance the reflects forward discussed, adjusted trends, category key I Roz from a color the given outlook uncertainty. EPS are ‘XX an cautious contribution and will As our assumptions overall more to revised guidance. macroeconomic underpinning Later, $X.XX. This view lower updated continued more lowering and provide consumer our
income incentive operating sale percentage Adjusted let's But constant leaseback from X.X% ownership, partly at included increased quarter results reduced look in detail. COVID-XX a first, drag third from accruals. and point This gains X% by a and offset XX basis. on the headwind a more AmerisourceBergen currency and
All out of an these items X% growth. net to headwind AOI approximately to
GAAP after basis to net prior $XXX licenses a U.K. $XXX million. earnings $XXX included X.X% quarter million, current the to charge compared of impairment $XXX earnings on in related year. a pharmacy declined to increased Adjusted a million currency The net million tax constant
to let's net down year-to-date ownership XX the a XX.X%, GAAP basis. reduced to X of on and currency loss in of increased reflecting contribution move billion highlights. $X.X X.X% lower Adjusted were billion, AmerisourceBergen percentage points. a Year-to-date of percentage was a points sales XXXX. compared of earnings $X.X earnings Now COVID-XX EPS constant
related including and With year the for billion opioid after claims current $X.X tax charge lawsuits. a
a of to gross move point with decline increased to The Sales negative SG&A stake in AOI percentage X%. segment. X.X% the X% expense impact X profit COVID-XX, declined the income. quarter led profit the of ABC up gross U.S. offset Adjusted Pharmacy of let's decline X.X% and to down inclusion of more a our AOI X.X% growth Now AmerisourceBergen X.X%. comp sales reflecting year-on-year, Retail than equity a before reduction the from slight led in sell
inflation. both script to advanced on Pharmacy. comparable turn and basis, increased sales brand driven U.S. now growth me by a and X.X% Pharmacy Let X.X%
Excluding a prior from reflecting and quarter broader the comp scripts market deceleration immunizations, prescription grew trends. slight X.X%,
of although As expected, cost than goods profit lower reimbursement offset profit adjusted pressure. gross growth excluding gross more declined sold increased COVID, as year-on-year, script and
our to next retail Turning U.S. business.
a quarters third through backdrop. in retail several the as some consumer very quarter good headwinds navigated encountered Following performance, business the macroeconomic the difficult of
seasonal holiday sales pulled Excluding by COVID-XX sales X.X%, kits. tobacco, comp weakness to XX basis spending back discretionary held basis due XX grew points and due to back consumers as lower OTC points on test of
flat, quarter and third but decline incidences. up versus beauty, in the cold cold range. in fan saw shows in X% sales flu, flu and data second X.X% in in down the significantly a grocery household, May due increase slowed with We respiratory activity, the up XX% a solid to X.X%. growth mid-XX% IQVIA and down respiratory were Cough in quarter, May,
expansion, quarters recent market pressure Following with year-on-year several similar XX-week seen in under around We've units, modest as retail of consecutive gross came period. quarter. trends margin in the most promotional third our margin the up broader the X%
However, more than margin increased effective has by XXX management. on points, a year-to-date gross by basis, driven basis margin
XX%, a Turning up the from International Adjusted operating X%. U.K. well. The continues despite numbers. headwind and always, with across as of year-on-year transactions. good to currency million and income wholesale was next segment to sale Sales markets. X% Boots and talk $XXX leaseback increased increased I'll all segment $XX grew very growth to Germany international international perform XX%, million constant
look now And a across U.K. skincare comp Future retail We at pharmacy same than with increased Boots.com Renew, sales and XX% in XX% XX%. the pre-COVID innovative year-on-year, sales and Boots market share comp launched comp recently Boots.com. response. of product line Boots gains detail XX%, equivalent versus of This comes U.K. positive successfully on launched last consumer now the more have for categories. retail in very was ninth range Boots Walgreens. year. Over XX% from U.K. with all in a grew grew quarter grew quarter. comes of X%, our doubled sales consecutive new more the advanced Let's sales top sales this quarter
existing $X.X U.S. next billion XX%. was the continues sales rapidly the forma year, up an were XX% Turning $X ongoing sales Healthcare Legacy business Healthcare. The with reaching more prior forma on was in than additional VillageMD the and maturation growth past scale clinics by to opened XX doubling basis. billion, year clinic pro clinics. to U.S. from with of driven the footprint, pro VillageMD expansion growth a sales of
delivered contract health a by season that approximately of impacted to Summit led addition Shields across sales partnerships. however, expansion was, strong existing up referrals fewer growth with quarter, another and driven the of Health by system forma Summit visits CityMD and weaker million and Network. respiratory fewer XX% including new the CareCentrix XX%. further $XXX of six were partners pro wins, Health sales
growth and clinic been Summit the Adjusted expansions. at improvement Health, patient lower offset EBITDA [tunnels] loss at by new visit has by Shields. the (ph) EBITDA reflects and CityMD profile cost We partly results whereas VillageMD continued fourth weaker-than-expected with in anticipate sales. VillageMD and quarter impacted volume, align build traffic reflects the as we
risk year-over-year Let's now of the full based in at VillageMD and Healthcare based include the key end, XXX,XXX XXX,XXX managed reflecting the of lives. look lives for addition at based from Business. some value lives VillageMD U.S. of metrics growth XX% legacy quarter value value Total XXX,XXX business approximately Summit. the lives
Our robust expand a clinical contracts trials and business continues signed with to pipeline. eight
billion earnings $X.X free to initiatives. flow expenditures increased million. The cash working due operating year-over-year lower of contribution $XXX a We decline cash cash flow. from to and lower capital to capital generated related reflected growth next of with COVID-XX, Turning flow,
we projects are to reduce our of spend of capital ahead, optimization rolling capital plan initiatives set and Looking are generation. out to working comprehensive cash enhance reprioritizing
guidance. to now Turning
We a updating to decline $X.XX, around adjusted guidance currency of our XX%. EPS are constant full-year ‘XX $X.XX
spring have to faster vaccinations. has expectations COVID COVID-XX XX million And adjusted core assumptions beginning our pace. the of of EPS $X.XX reduced booster of COVID-XX up testing At at our despite contribution than is fiscal year, Excluding we X%. and vaccinations. an at ForEx XX.X the the recommendation, even is the to The EPS decelerated the impact million original from year. start flat lower the we expected full-year
quarter incorporated of Additionally, as $X.XX realign the a goals outlook, we to sales consumer to have more impacts fourth recent and reflect we to cautious leading trends. margin impact $X.XX a our
$X.XX led headwind. reducing in Finally, stake to while our has a improved has, our however, It position. ownership debt AmerisourceBergen
a billion X assumptions Starting XX% XX%, U.S. project up of to segments. we Let billion, decline me with $XXX for percentage now $X.X is business and $X.X through reduced XX Retail stake from our of now in to Pharmacy, point reflecting projected sales AOI points walk a AmerisourceBergen. COVID-XX year-on-year. around low-single-digits of you headwind from percentage our each ownership at our billion,
two AOI X% these X%. Excluding up impacts, to growth is
around International original our towards is the the the of are operating income to which performance XX%. U.K. especially segment, This basis, to a top represents is $XXX next Turning of strong constant year. million, well approximately performing execution, X% Sales this to end in constant grow Adjusted expectations. of currency growth X% projected on currency reflecting
for CityMD, into ramp new U.S. VillageMD outlook Summit's at of slower visits continued prior reflects of integration revised sites Healthcare Our multi-specialty business. up and lower the the acquisitions
We basis. expect pro versus billion year prior sales $X.X a XX% $X.X on increase billion, and of billion growing approximately $X.X an a of to form
are million $XXX factors earlier. I including of loss mentioned We projecting an adjusted million, to the EBITDA $XXX
profit the we far plan, adjusted and underway, improvement and quarter drive expect actions year rapid fourth are EBITDA performance has While to the below correction been this so beyond. sequential in
to with average guidance we the quarter tax approximately result assumptions, $X.XX of quarter. quarter rate lowest rate EPS $X.XX typically have reflects More tax a so far to now and the the rate fiscal of is fourth fourth our XX%. expected by corporate quarter this tax in weighed down seen of higher basically extrapolate now implies some The full-year to quarter. the the expect XX% to $X.XX. is fourth is the specifically, be favorability around Full-year $X.XX of in the fourth much our reversing to benefits and Turning ‘XX, around we
proxy a as quarter for the extrapolate to incorrect be would XXXX. it such As
the result additional First, tax rate normalizing $X.XX would quarter. for in an in the
our businesses. Second, seasonality of impacts all
and adjusted ABC, five of EPS an annual the adjusted excluding the the in of COVID-XX share. past the accounting around tax impact fourth seasonality income rate, comes would quarter. operating XX% adjusting quarter over approximately and our per To conclude, back in from fourth for years, Looking result for $X
would like the cover key expect long-term to the I we outweigh near-term tailwinds factors pressures. XXXX will influence Overall, Next, the performance. that to
with we challenges spending, expect faced some in in in do are labor the of to ‘XX. continued ‘XX increases Some We expected to together see consumer weakness fiscal into costs. continue moderate
pressure. pressure offset somewhat not past and away over continue way While it the has going is identify the reimbursement XX we will eased to months, to
activity as a statutory addition In leaseback lap Switzerland. favorable be in rates performance sale rate expect we ‘XX the the very fiscal and higher and and we will lower U.K. tax and fiscal introduced in are tax ‘XX, higher both
we significant However, a U.S. and a maturing to profile drivers profit business initiatives profitability. have multiple sustainable Our Summit profit the clinic will first path Healthcare that profit strong actions driver, including drive VillageMD accelerate their to of be full-year and will Health, growth
We gains of script initiatives. expect and of volume performance These the contribution include successful penetration improvement program. own and continued from growth category strong further brand store front expansion our
transformational Lastly, the management million year. will $XXX least program cost of deliver savings at next
a deeper XXXX. into look Next, let's take
adjusted Retail led U.S. We to segment XXXX Pharmacy. the execution income in operating and solid low-to-mid-single-digits, expect Healthcare by fiscal U.S. grow
profitability. provide are expecting rapidly We U.S. gaining the to business we the will EBITDA accelerate total taking on delivery. and the as the of color company path Healthcare more are is John immediate to Driscoll driver now actions accelerate we will growth, much be to largest scale, AOI
step AOI management of to core sale items, $XXX contributions gross cost slightly, lower Pharmacy gains. and by solid $XXX a and profit. We led due these expanding down down transformational be anticipate Retail savings and COVID flat growth approximately we in program million leaseback to Absent to expect U.S. million
and lap the manages as inflation. growth Finally, for as lose presence. sale to interest. international and business due will said, being business growth real an non-controlling of contribution high profit decline estate AOI flat AOI well the outpace in success AOI rate the Core to cost year-on-year relatively business share e-commerce Chile. small of expect We a to is levels and and through labor be our gains growing we expect That we with gains EPS, from long-term and our International sizable tax higher positioned do market advantaged
in Pharmacy more Next, detail. we'll look at U.S.
gross growth tech our offerings. up COVID, enabled clinical and pharmacy more to we spend Underpinning time grow service the model, on expect our profit. programs Excluding frees which for differentiated supporting operating to pharmacy is capacity pharmacists expanding
improved are and operating growth solid We from lives script hours, in growth increased to projecting benefiting access specialty.
pharmacies under payer provider-centric a integrating new and approach. strategy with are a Shields We specialty AllianceRx community-based agnostic go-to-market
we for addition, U.S. pharmacy across that have and initiatives from to launched our integrated clinical In and continue multiple healthcare quality engagement leverage our see assets. partners programs business and payers
Moving now improvement. by Retail Gross continued profit U.S. margin driven and be business. comp growth to will low-single-digit growth our
creating assortment in significant savings where through performance value fiscal are of decisions should $XXX We at least management, category deliver XXXX. million
are higher our accelerating We of innovation brands increased significantly display, penetration points brands. national own through and margins our are and brand than own distribution have that
more scale store We value including store health a we feedback evolve on both and concepts. a consumers store with platform are and our concept formats, forward as e-commerce for early new focused our creating favorable digital wellness and
me drivers. Let profit hand now our strategy U.S. to growth to and it over Healthcare discuss John